Exosomes Market Size

Exosomes Market size is expected to cross USD 5.3 Billion by the end of 2036, growing at a CAGR of 16% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of exosomes was over USD 776 million. The growth of the market is due to an increase in percentage of the people suffering from neurodegenerative diseases which is the main cause of death and disability, as well as a significant financial strain on healthcare systems. In strongly growing nations, the number of dementia cases is predicted to rise from 13.5 million in 2000 to 21.2 million in 2025 and 36.7 million in 2050, according to a United Nations assessment.

In addition to these, the market is growing since major firms have been making developments on exosome therapies. For example, in 2021, the biotechnology research company Cell Guidance Systems, located in the United States, announced that it would be creating exosome therapies to treat COVID-19. Furthermore, there will probably be a significant increase in government and non-government initiatives for exosome research during the study period.